Some of the properties set to be auctioned

Equity Bank Uganda and Equity Bank Kenya have insisted that the planned auction of properties belonging to businessman Dr Mathias Magoola’s companies to recover over Shs 148 billion loans will proceed, dismissing a legal warning issued to prospective buyers against participating in the sale.

The banks, through their lawyers Katende, Ssempebwa and Company Advocates, maintain that the proposed auction is lawful and that no court order has been issued to stop or suspend the sale.

In a public notice titled Response to Caveat Emptor, the lawyers urged members of the public to disregard a warning published by Muwema and Company Advocates on November 9, 2026, cautioning prospective buyers against purchasing the properties.

“We are writing to confirm to the public that the said public auction is proceeding under the auspices of the Mortgage Act, Cap 239 Laws of Uganda and is legal and lawful and not in contempt of any court proceedings,” the lawyers stated.

They added: “We also confirm that there is no order of any court staying or stopping the proposed sale.”

The response follows a November 5 advertisement by JALD (U) Ltd, which announced the intended sale by public auction or private treaty of several properties mortgaged as security for loans obtained by Dei BioPharma Ltd and Dei Industries International Ltd from the two banks.

The auction notice lists several commercial, industrial and residential properties in Kampala and Wakiso districts, including the pharmaceutical manufacturing facility at Matugga, a wheat milling plant in Luzira and properties in Kyamuli-Kungu, Katwe, Muyenga, Kitende and Seguku.

The Matugga establishment, associated with Dei’s pharmaceutical manufacturing project, occupies approximately 20.673 acres.

The proposed sale has exposed a longstanding dispute between the banks and the Dei companies over outstanding loan balances and the process used to establish the amounts owed.

Through Muwema and Company Advocates, the companies and Magoola have argued that the auction is premature because the outstanding debt remains contested and court proceedings relating to the loan audit have not been concluded.

The companies previously challenged the independence and integrity of the audit process, which was intended to establish their outstanding obligations to the lenders.

The dispute escalated after the Court of Appeal reportedly stayed proceedings in the underlying High Court case on September 9, 2026, pending determination of an appeal relating to the contested audit process.

The banks, however, maintain that the court order does not prevent them from exercising their rights under the mortgages securing the loans.

The planned disposal has also attracted public interest because of the government’s reported investment of Shs 723.4 billion in Dei BioPharma, which is developing a pharmaceutical manufacturing facility at Matugga.

The Parliamentary Committee on Presidential Affairs has previously raised concerns about accountability, operational performance and documentation relating to the government’s investment in the company.

The competing legal notices leave prospective buyers with conflicting positions from the two sides over the proposed transaction. While the banks have invited the public to participate in the auction, Dei’s lawyers have cautioned against purchasing the properties, arguing that the sale is being pursued before the loan dispute is resolved.

Leave a comment

Your email address will not be published. Required fields are marked *